)
Quest Diagnostics (DGX) investor relations material
Quest Diagnostics Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Q3 2025 revenues rose 13.1% year-over-year to $2.82 billion, driven by strong demand for clinical solutions, consumer channel expansion, and recent acquisitions including LifeLabs and select assets from Spectra Laboratories and Fresenius Medical Care.
Reported diluted EPS for Q3 was $2.16, up 8.5% year-over-year; adjusted diluted EPS was $2.60, up 13.0%.
Raised full-year 2025 guidance for revenues and EPS based on strong year-to-date performance and continued momentum in clinical innovations and consumer channels.
Announced major collaborations and technology partnerships, including a joint venture with Corewell Health, Project Nova with Epic, and partnerships with consumer health brands.
Year-to-date cash from operations totaled $1.42 billion, up 63.1% year-over-year, driven by higher operating income, working capital timing, and tax credits.
Financial highlights
Q3 2025 consolidated revenues were $2.82 billion, up 13.1% year-over-year; nine-month revenues totaled $8.23 billion, up 13.5%.
Operating income for Q3 2025 was $386 million (13.7% margin), with adjusted operating income at $458 million (16.3% margin), both up from prior year.
Net income attributable to shareholders was $245 million for Q3 2025, up 8.5% year-over-year.
Cash provided by operations in Q3 2025 was $563 million, up 57.4% year-over-year; capital expenditures for Q3 were $144 million, up 37.0%.
Diagnostic Information Services revenues increased 13.5% year-over-year, with total volume up 12.5% and organic volume up 3.9%.
Outlook and guidance
Full-year 2025 revenue guidance raised to $10.96–$11.00 billion, reflecting 11.0–11.4% growth; adjusted EPS expected at $9.76–$9.84, reported EPS at $8.58–$8.66.
Cash from operations expected to be approximately $1.8 billion; capital expenditures projected at $500 million.
Guidance assumes 4.5–5% organic revenue growth plus contributions from 2024 acquisitions; includes investments in Project Nova.
Operating margin expected to expand versus prior year.
OBBBA and expiration of enhanced Premium Tax Credits are not expected to materially impact 2025–2026 revenues.
Next Quest Diagnostics earnings date
Next Quest Diagnostics earnings date
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)